An Unusual Presentation of Plasma Cells – Castleman Disease: A Case Report

1. MAGRINI U, LUCIONI M, INCARDONA P, BOVERI E, PAULLI M. Castleman's disease: update. Pathologica, 2003; 95(5):227-9.Search in Google Scholar

2. KELLER AR, HOCHHOLZER L, CASTLEMAN B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29:670-683.10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#Search in Google Scholar

3. BATES DO, HARPER SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002; 39:225-237.10.1016/S1537-1891(03)00011-9Search in Google Scholar

4. PEH SC, SHAMINIE J, POPPEMA S, KIM LH. The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease. Singapore Med J. 2003; 44:185-191.Search in Google Scholar

5. MENKE DM. Ly-1b cells and Castleman Disease. Blood. 2000; 96:1614-1616.10.1182/blood.V96.4.1614Search in Google Scholar

6. CHEN WC, JONES D, HO CL et al. Cytogenetic anomalies in hyaline vascular Castleman disease: report of two cases with reappraisal of histogenesis. Cancer Genet Cytogenet 2006; 164:110-111.10.1016/j.cancergencyto.2005.06.009Search in Google Scholar

7. CRONIN DM, WARNKE RD. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009; 16:236-246.10.1097/PAP.0b013e3181a9d4d3Search in Google Scholar

8. LEE J, BAN JY, WON KY, et al. Expression of EGFR and folicullar dendritic markers in lymphoid follicles from patients with Castleman’s disease. Oncol Rep 2008; 20:851-856.Search in Google Scholar

9. NGUYEN DT, DIAMOND LW, HANSMANN ML, et al. Castleman’s disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology 1994; 24:437-443.10.1111/j.1365-2559.1994.tb00552.xSearch in Google Scholar

10. HALL PA, DONAGHY M, COTTER FE, STANSFELD AG, LEVISON DA. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology 1989; 14:333-346.10.1111/j.1365-2559.1989.tb02162.xSearch in Google Scholar

11. WEISENBURGER DD, NATHWANI BN, WINBERG CD, RAPPAPORT H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum. Pathol. 1985; 16:162-172.Search in Google Scholar

12. NICOLOSI AC, ALMASSI GH, KOMOROWSKI R. Cardiac tamponade secondary to giant lymph node hyperplasia (Castleman's disease). Chest 1994; 105(2):637-639.10.1378/chest.105.2.637Search in Google Scholar

13. SHAHIDI H, KVALE PA. Cardiac tamponade secondary to giant lymph node hyperplasia. Chest 1995; 107(2):581.10.1378/chest.107.2.581Search in Google Scholar

14. ZHANG C, MIAO Q, CHEN G, LIU X, MA G, CAO L, DENG H. Pericardial tamponade secondary to Castleman’s disease. Ann Thorac Surg. 2009; 88(6):2039.10.1016/j.athoracsur.2009.05.064Search in Google Scholar

15. SHIKAMA N, ISONO A, OTSUKA Y, TERANO T, HIRAI A. A case of POEMS syndrome with high concentrations of interleukin 6 in pericardial fluid. J Intern Med. 2001; 250(2):170.10.1046/j.1365-2796.2001.00863.xSearch in Google Scholar

16. BOWNE WB, LEWIS JJ, FILIPPA DA, et al. The management of unicentric and multicentric Castleman disease; a report of 16 cases and a review of the literature. Cancer. 1999; 85:706-717.10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7Search in Google Scholar